- Package
- 1 g
- Purity
- 98%
- Price
- Request review
- Availability
- Shipping review required
- Delivery
- Shipping review required
CAS Number: 202475-60-3
Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.
Available options
Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.
CAS Number
202475-60-3
PubChem CID
3794
Molecular Formula
C16H15N3O3
Molecular Weight
297.31 g/mol
Exact Mass
297.111341
InChIKey
HOZUXBLMYUPGPZ-UHFFFAOYSA-N
IUPAC Name
4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol
SMILES String
COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)O)OC
No physical property values available.
Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.
Structural features
Whi-p131 (CAS 202475-60-3) is listed in the Advanced Chemicals portfolio, with molecular formula C16H15N3O3 and molecular weight 297. 31 g/mol.
Sourcing context
Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.
Research use context
Intended for research building-block and synthetic chemistry workflows; structure-derived tags include nitrogen-containing heterocycle.
Documentation needs
COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.
ChEMBL reports experimental activity evidence for: Proto-oncogene tyrosine-protein kinase receptor Ret (Homo sapiens) — 2 assays; Epidermal growth factor receptor (Homo sapiens) — 2 assays; ALK tyrosine kinase receptor (Homo sapiens) — 2 assays; Vascular endothelial growth factor receptor 2 (Homo sapiens) — 2 assays; Tyrosine-protein kinase JAK1 (Homo sapiens) — 2 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.
Proto-oncogene tyrosine-protein kinase receptor Ret
Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 2 documents · best pChEMBL 6.14
Experimental evidence source: ChEMBL
Epidermal growth factor receptor
Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 2 documents · best pChEMBL 5.93
Experimental evidence source: ChEMBL
ALK tyrosine kinase receptor
Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 2 documents · best pChEMBL 5.62
Experimental evidence source: ChEMBL
Vascular endothelial growth factor receptor 2
Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 2 documents · best pChEMBL 5.55
Experimental evidence source: ChEMBL
Tyrosine-protein kinase JAK1
Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 2 documents
Experimental evidence source: ChEMBL
For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.
Preliminary Safety Reference
For supplier-issued SDS or COA, submit a documentation request.
Safety Reference / SDS RequestCatalog navigation
Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.
Whi-p131 is identified by CAS 202475-60-3, with molecular formula C16H15N3O3, molecular weight 297.31, InChIKey HOZUXBLMYUPGPZ-UHFFFAOYSA-N.
ChEMBL contains qualifying experimental assay evidence associated with Proto-oncogene tyrosine-protein kinase receptor Ret, Epidermal growth factor receptor, ALK tyrosine kinase receptor, Vascular endothelial growth factor receptor 2, Tyrosine-protein kinase JAK1. These records do not establish therapeutic efficacy or clinical use.
Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.
Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.
Availability, pack size, lead time, and pricing are confirmed through RFQ.
Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.